Effect of antimicrobial exposure on AcrAB expression in Salmonella enterica subspecies enterica serovar Choleraesuis

Frontiers in Microbiology

Volumn 4, Issue MAR, 2013, Pages

  Usui, Masaru ^a,b   Nagai, Hidetaka ^a   Hiki, Mototaka ^a   Tamura, Yutaka ^b   Asai, Tetsuo ^a  

^a NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

AcrAB efflux pump; Antimicrobial resistance; RamA; Salmonella choleraesuis; SoxS

Indexed keywords

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA CHOLERAESUIS; SALMONELLA ENTERICA;

EID: 84875879550     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00053     Document Type: Article

References (22)

1. Abouzeed, Y.M., Baucheron, S., and Cloeckaert, A. (2008). ramR mutations involved in efflux- mediated multidrug resistance in Salmonellaenterica serovar Typhimurium. Anti microb.Agents Chemother. 52, 2428-2434.
2. Asai, T., Namimatsu, T., Osumi, T., Kojima, A., Harada, K., Aoki,H., etal. (2010).Molecularty pingand anti microbial resistance of Salmonellaenterica sub species enterica serovar Choleraesuis isolates from diseased pigs in Japan. Comp. Immunol.Microbiol.Infect.Dis. 33, 109-119.
3. Bailey, A.M., Paulsen, I.T., and Piddock, L.J. (2008).RamA confers multidrug resistance in Salmonellaenterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob. Agents Chemother. 52, 3604-3611.
4. Chen, S., Cui, S., McDermott,P.F., Zhao, S., White, D.G., Paulsen, I., etal. (2007). Contribution of target genemutations and efflux to decreased susceptibility of Salmonella enterica serovar Typhimurium to fluoroquinolones and other antimicrobials. Antimicrob. Agents Chemother. 51, 535-542.
5. Chiu, C. H., Su, L. H., and Chu, C. (2004). Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin. Microbiol. Rev. 17, 311-322.
6. Clinical and Laboratory Standard Institute. (2008). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, Third Edition: Approved Standard M31-A3. Wayne, PA: Clinical and Laboratory Standard Institute.
7. Giraud, E., Cloeckaert, A., Kerboeuf, D., and Chaslus-Dancla, E. (2000). Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44, 1223-1228.
8. Kim, K. Y., and Woo, G. J. (2011). Expression of acrB and ramA in fluoroquinolone resistant mutants from multi-drug resistant Salmonella enterica serovar Haardt. Lett. Appl. Microbiol. 52, 484-490.
9. Lee, H. Y., Su, L. H., Tsai, M. H., Kim, S. W., Chang, H. H., Jung, S. I., et al. (2009). High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia. Antimicrob. Agents Chemother. 53, 2696-2699.
10. Li,X. Z., and Nikaido, H. (2004). Effluxmediated drug resistance in bacteria. Drugs 64, 159-204.
11. Li, X. Z., and Nikaido, H. (2009). Effluxmediated drug resistance in bacteria: an update. Drugs 69, 1555-1623.
12. Nikaido, E., Yamaguchi, A., and Nishino, K. (2008). AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J. Biol. Chem. 283, 24245-24253.
13. Olliver, A., Valle, M., Chaslus-Dancla, E., and Cloeckaert, A. (2004). Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol. Lett. 238, 267-272.
14. ORegan, E., Quinn, T., Pages, J. M., McCusker, M., Piddock, L., and Fanning, S. (2009). Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrob. Agents Chemother. 53, 1080-1087.
15. Ricci, V., and Piddock, L. J. (2009a). Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways. J. Antimicrob. Chemother. 63, 909-916.
16. Ricci, V., and Piddock, L. J. (2009b). Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium. J. Antimicrob. Chemother. 64, 654-657.
17. Ricci, V., Tzakas, P., Buckley, A., and Piddock, L. J. (2006). Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob. Agents Chemother. 50, 38-42.
18. Rosenberg, E. Y., Bertenthal, D., Nilles, M. L., Bertrand, K. P., and Nikaido, H. (2003). Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48, 1609-1619.
19. Usui, M., Asai, T., and Sato, S. (2011). Low expression of acrB in the deoxycholate-sensitive strains of Salmonella enterica subspecies enterica serovar Pullorum. Microbiol. Immunol. 55, 366-368.
20. Usui, M., Uchiyama, M., Baba, K., Nagai, H., Yamamoto, Y., and Asai, T. (2010). Contribution of enhanced efflux to reduced susceptibility of Salmonella enterica serovar Choleraesuis to fluoroquinolone and other antimicrobials. J. Vet. Med. Sci. 73, 279-282.
21. Usui, M., Uchiyama, M., Iwanaka, M., Nagai, H., Yamamoto, Y., and Asai, T. (2009). Intracellular concentrations of enrofloxacin in quinolone-resistant Salmonella enterica subspecies enterica serovar Choleraesuis. Int. J. Antimicrob. Agents 34, 592-595.
22. Zheng, J., Cui, S., and Meng, J. (2009). Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J. Antimicrob. Chemother. 63, 95-102.